TILT Biotherapeutics From Finland Secures €10M for Viral Cancer T-Cell Immunotherapy
14 December 2016
14 December 2016
Total investments received (USD): 62.39m
Round value (USD): 10.63m
Round investors:
Lifeline Ventures
Business Finland
Company: TILT Biotherapeutics
Industry:
Biotech
Health services
Related deals
BC Platforms secures USD $10 million Series B Financing led by Debiopharm and Tesi to further grow its genomic knowledge platform development.
Investments
09 May 2017
Dermtreat completes a USD 17.7 mill. Series A financing led by Sofinnova.
Investments
08 May 2017
Mentis Cura raised seed money
Investments
24 December 2016
Visedo, the Finnish-based electrical maunfacturer, raises 20M EUR financing round with Emerald Technology Ventures as the lead investor.
Investments
19 December 2016
Finnish KNL Networks raises $10 million Series A investment from Creandum and existing seed investors Inventure and Butterfly Ventures.
Investments
27 October 2016
Belgium
Netherlands
Austria
Germany
Estonia
Iceland
Latvia
Lithuania
Ireland
Italy
Portugal
Spain